Skip Navigation Bar
NLM logo

Unified Medical Language System® (UMLS®)

2009AB FDA National Drug Code Directory Source Information

Counts

 (skip to: notes  samples)

RelationshipRelationship AttributeCount (MRREL.RRF)
RO included_in 313

Notes

Sample data are taken from MRREL.RRF. Associated strings(str) from MRCONSO.RRF are also included

  • See relationships definitions below.
  • Every relationship has a separate row in MRREL.RRF.
  • Relationships are assigned based on source documentation or NLM understanding of the source.
  • Metathesaurus relationships in MRREL.RRF are read from right to left.
  • All relationships in MRREL.RRF are expressed in both directions, for example: 'has_ingredient/ingredient_of'. Inverse relationships in each pair are indicated on this page.
  • An asterisk (*) in the relationship attribute column indicates that no relationship attribute (RELA) was assigned.
  • Every even row (indicated by orange colored rel/rela pairs) indicates that the current row is an inverse relationship of the row above it.
  • See section 2.7.1.3.9 in UMLS Documentation Section 2, Metathesaurus for more information on Related Concepts, MRREL.RRF.

Relationship Definitions

  • AQ: allowed qualifier
  • CHD: has child (narrower hierarchical term)
  • DEL: deleted concept
  • PAR: has parent (broader hierarchical term)
  • QB: can be qualifier by
  • RB: has a broader relationship
  • RL: has similar or like relationship
  • RN: has narrower relationship
  • RO: has relationship other than synonymous, narrower or broader
  • RQ: related and possibly synonymous
  • SIB: has sibling
  • SY: source-asserted synonymy

Sample Data

RO

  (return to top)
CUI1AUI1STYPE1STRRELRELASTRSTYPE2AUI2CUI2
C2369426 A16025421 AUI TISSEEL KIT 90 MG/ML/500 RO included_in TISSEEL KIT 90 MG/ML/500_#4 AUI A16033107 C2370724
C2370724 A16033107 AUI TISSEEL KIT 90 MG/ML/500_#4 RO includes TISSEEL KIT 90 MG/ML/500 AUI A16025421 C2369426
C2718283 A10467027 AUI LORAZEPAM 2 MG INTRAVENOUS INJECTION, SOLUTION RO included_in LORAZEPAM 2 MG INTRAVENOUS INJECTION, SOLUTION_#2 AUI A16947765 C0978252
C0978252 A16947765 AUI LORAZEPAM 2 MG INTRAVENOUS INJECTION, SOLUTION_#2 RO includes LORAZEPAM 2 MG INTRAVENOUS INJECTION, SOLUTION AUI A10467027 C2718283
C1971035 A10669211 AUI FLUTICASONE PROPIONATE 100 MCG / SALMETEROL XINAFOATE 50 MCG RESPIRATORY (INHALATION) INHALANT [ADVAIR] RO included_in FLUTICASONE PROPIONATE 100 MCG / SALMETEROL XINAFOATE 50 MCG RESPIRATORY (INHALATION) INHALANT [ADVAIR]_#3 AUI A13278213 C2365544
C2365544 A13278213 AUI FLUTICASONE PROPIONATE 100 MCG / SALMETEROL XINAFOATE 50 MCG RESPIRATORY (INHALATION) INHALANT [ADVAIR]_#3 RO includes FLUTICASONE PROPIONATE 100 MCG / SALMETEROL XINAFOATE 50 MCG RESPIRATORY (INHALATION) INHALANT [ADVAIR] AUI A10669211 C1971035
C1963601 A10700788 AUI CROMOLYN SODIUM 800 MCG INHALATION INHALANT [INTAL] RO included_in CROMOLYN SODIUM 800 MCG INHALATION INHALANT [INTAL]_#2 AUI A13272157 C1966438
C1966438 A13272157 AUI CROMOLYN SODIUM 800 MCG INHALATION INHALANT [INTAL]_#2 RO includes CROMOLYN SODIUM 800 MCG INHALATION INHALANT [INTAL] AUI A10700788 C1963601
C1963102 A12942861 AUI SODIUM CHLORIDE 9 MG INTRAVASCULAR INJECTION RO included_in SODIUM CHLORIDE 9 MG INTRAVASCULAR INJECTION_#2 AUI A13277230 C1962257
C1962257 A13277230 AUI SODIUM CHLORIDE 9 MG INTRAVASCULAR INJECTION_#2 RO includes SODIUM CHLORIDE 9 MG INTRAVASCULAR INJECTION AUI A12942861 C1963102

Last Reviewed: April 25, 2011